BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25612239)

  • 1. Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
    Read RL; Flitcroft K; Snook KL; Boyle FM; Spillane AJ
    ANZ J Surg; 2015 May; 85(5):315-20. PubMed ID: 25612239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future role of neoadjuvant therapy for breast cancer.
    Untch M; Konecny GE; Paepke S; von Minckwitz G
    Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in the treatment of breast cancer.
    Redden MH; Fuhrman GM
    Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer].
    Kobayashi T; Yamazaki H; Nakamura T; Ogihara A; Fujii T; Hirano A; Uno S; Yoshida K; Nagata T; Uchida K; Kubo H; Tozaki M; Kanehira C; Miyazawa Y; Suzuki M; Kuraishi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1814-25. PubMed ID: 11729473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving surgery in the neoadjuvant setting.
    Brenin DR; Morrow M
    Semin Oncol; 1998 Apr; 25(2 Suppl 3):13-8. PubMed ID: 9566202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
    Loibl S; von Minckwitz G; Raab G; Blohmer JU; Dan Costa S; Gerber B; Eidtmann H; Petrich S; Hilfrich J; Jackisch C; du Bois A; Kaufmann M
    Ann Surg Oncol; 2006 Nov; 13(11):1434-42. PubMed ID: 16983592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].
    Fukutomi T
    Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):803-5. PubMed ID: 12478855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for operable breast cancer.
    Green M; Hortobagyi GN
    Oncology (Williston Park); 2002 Jul; 16(7):871-84, 889; discussion 889-90, 892-4, 897-8. PubMed ID: 12164555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
    Mamounas EP
    Ann Surg Oncol; 2008 Mar; 15(3):691-703. PubMed ID: 18196346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy.
    Bear HD
    Surg Oncol Clin N Am; 2010 Jul; 19(3):607-26. PubMed ID: 20620930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.
    Akashi-Tanaka S; Fukutomi T; Sato N; Iwamoto E; Watanabe T; Katsumata N; Ando M; Miyakawa K; Hasegawa T
    Ann Surg; 2004 Feb; 239(2):238-43. PubMed ID: 14745332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemotherapy does not Increase Complications in Oncoplastic Breast-Conserving Surgery.
    Adamson K; Chavez-MacGregor M; Caudle A; Smith B; Baumann D; Liu J; Schaverien M
    Ann Surg Oncol; 2019 Sep; 26(9):2730-2737. PubMed ID: 31037439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
    Kim R; Osaki A; Toge T
    Clin Breast Cancer; 2005 Aug; 6(3):223-32; discussion 233-4. PubMed ID: 16137432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the indication for breast-conservative surgery (BCS) in patients with locally-advanced breast cancer.
    Mazilu L; Suceveanu AI; Tomescu D; Ciufu N; Baz R; Suceveanu AP; Parepa IR; Tofolean DE; Voinea F
    Chirurgia (Bucur); 2013; 108(4):478-81. PubMed ID: 23958089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant Chemotherapy in breast cancer].
    Suzuki E; Toi M
    Nihon Rinsho; 2006 Mar; 64(3):536-9. PubMed ID: 16529046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.